Vanessa Arguello, MD; Matthew Freeby, MD
Disclosures: Authors have disclosed no conflicts of interest. Forms can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M17-2121.
Requests for Single Reprints: Vanessa Arguello, MD, David Geffen School of Medicine at UCLA, 1245 16th Street, Suite 307, Santa Monica, CA 90404; e-mail, firstname.lastname@example.org.
Current Author Addresses: Dr. Arguello: David Geffen School of Medicine at UCLA, 1245 16th Street, Suite 307, Santa Monica, CA 90404.
Dr. Freeby: David Geffen School of Medicine at UCLA, 200 Medical Plaza Driveway, Suite 530, Los Angeles, CA 90095.
Arguello V, Freeby M. Continuous Glucose Monitoring in Patients With Type 2 Diabetes Receiving Insulin Injections: Does This Mean Continuous Glucose Monitoring for Everyone?. Ann Intern Med. 2017;167:436–437. [Epub ahead of print 22 August 2017]. doi: https://doi.org/10.7326/M17-2121
Download citation file:
Published: Ann Intern Med. 2017;167(6):436-437.
Published at www.annals.org on 22 August 2017
Cardiology, Coronary Risk Factors, Diabetes, Endocrine and Metabolism.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use